Cantoni
1 known investors
Cantoni Therapeutics is a biotech company developing small molecule bisubstrate inhibitors of the enzyme nicotinamide N-methyltransferase (NNMT) as a treatment for obesity and its cardiometabolic complications such as type 2 diabetes and cardiovascular disease. Its inhibitor portfolio targets both the SAM and NA binding pockets of NNMT, aiming to offer an alternative to appetite-reducing anti-obesity medications.
BiotechDeep TechHealthtech
Investors · 1
Frequently asked questions
- What does Cantoni do?
- Cantoni Therapeutics is a biotech company developing small molecule bisubstrate inhibitors of the enzyme nicotinamide N-methyltransferase (NNMT) as a treatment for obesity and its cardiometabolic complications such as type 2 diabetes and cardiovascular disease. Its inhibitor portfolio targets both the SAM and NA binding pockets of NNMT, aiming to offer an alternative to appetite-reducing anti-obesity medications.
- Who are Cantoni's investors?
- Cantoni's investors include BOM.